# Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment

> **NCT04634071** · PHASE2 · COMPLETED · sponsor: **Joseph Valentino, MD** · enrollment: 126 (actual)

## Conditions studied

- Smoking Cessation
- Cancer, Treatment-Related

## Interventions

- **DRUG:** Varenicline
- **DRUG:** Bupropion
- **DRUG:** Long-acting nicotine replacement therapy
- **BEHAVIORAL:** Low-intensity counseling
- **BEHAVIORAL:** High-intensity counseling
- **OTHER:** No nicotine replacement therapy
- **DRUG:** Nicotine Replacement Products

## Key facts

- **NCT ID:** NCT04634071
- **Lead sponsor:** Joseph Valentino, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-12
- **Primary completion:** 2026-01-02
- **Final completion:** 2026-01-02
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04634071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04634071, "Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04634071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*